|
AU2017210575A1
|
|
Anti-infective formulation and methods of use
|
|
AU2015261543A1
|
|
Controlled release compositions and their methods of use
|
|
AU2015218447A1
|
|
Animal Treatment Formulation and Methods of Use
|
|
NZ708025A
|
|
Reproductive dosage regime
|
|
AU2014201152A1
|
|
Tablet Formulation
|
|
WO2014051440A1
|
|
Ectoparasitic treatment method and composition
|
|
EP2874623A1
|
|
Injectable antibiotic formulations and their methods of use
|
|
TW201404393A
|
|
Injectable antibiotic formulations and their methods of use
|
|
AU2013290826A1
|
|
Injectable antibiotic formulations and their methods of use
|
|
TW201444585A
|
|
Antibiotic formulations
|
|
AU2013204134A1
|
|
Ectoparasitic Treatment Method and Composition
|
|
CN104168886A
|
|
Long acting compositions
|
|
WO2013129944A1
|
|
Controlled release compositions and their methods of use
|
|
NZ624064A
|
|
Improvements to delivery devices
|
|
MY167596A
|
|
Antibiotic formulations
|
|
NZ617203A
|
|
Ectoparasitic treatment method and composition
|
|
NZ629041A
|
|
Injectable antibiotic formulations and their methods of use
|
|
MX2013014460A
|
|
Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation.
|
|
NZ613078A
|
|
Ectoparasitic treatment method and composition
|
|
NZ608177A
|
|
Long acting compositions
|
